Home » Interviews » INTERVIEW: Microsaic Systems Plc New CEO Glenn Tracey
Microsaic Systems plc

INTERVIEW: Microsaic Systems Plc New CEO Glenn Tracey

Microsaic Systems Plc (LON:MSYS) CEO Glenn Tracey talks to DirectorsTalk about his new role, what mass detection is and its uses, the business model and what investors should be looking out for in terms of news flow over the coming months.

 

Glenn joined the Company in March 2015 as Chief Operating Officer and was appointed to the Board of Directors in December 2015. Glenn has 20 years of experience in product marketing and research and development, for both small and large companies in the healthcare technology industry, including PerkinElmer where he was central to the development, scale-up and commercialisation of disruptive sensing and detection technologies across multiple emerging application areas.

Microsaic Systems plc is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry (“MS”) instruments that are designed to improve the efficiency of pharmaceutical R&D. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic’s core product, the 4000 MiD®, is one of the smallest MS systems in the world, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!